Bank of New York Mellon Corp
BankPosition in HRTX — Heron Therapeutics, Inc. /De/
CIK 1390777
NEW YORK, NY
Position in HRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$170,208
-$155,236 QoQ
Shares Held
395,838
-2.7% QoQ
Ownership
0.208%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#35
of 160 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in HRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. HRTX ranks #284 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in HRTX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $170,208 | 395,838 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $325,444 | 406,806 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $544,018 | 418,477 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $519,716 | 412,474 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $832,368 | 402,111 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $722,351 | 328,342 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $521,285 | 340,710 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $678,068 | 340,739 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $1,572,241 | 449,212 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $929,491 | 335,557 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $687,427 | 404,370 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $363,995 | 353,395 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $387,497 | 334,050 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $506,195 | 335,229 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $873,537 | 349,415 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,467,022 | 347,636 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $868,668 | 311,351 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $1,743,072 | 304,733 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $2,728,509 | 298,851 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $3,547,336 | 331,837 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $4,649,573 | 299,586 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $5,519,082 | 340,474 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $7,523,075 | 355,365 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $5,307,248 | 358,114 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,430,327 | 369,159 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $4,174,213 | 355,555 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||